Accel Wealth Management Gilead Sciences, Inc. Transaction History

Accel Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$57.92 - $72.58 $1,274 - $1,596	-22 Reduced 16.79%	109 $6,000
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $2,011 - $2,282	31 Added 31.0%	131 $9,000
Q3 2021 Nov 04, 2021	SELL	$67.69 - $73.03 $2,030 - $2,190	-30 Reduced 23.08%	100 $7,000
Q2 2021 Aug 03, 2021	SELL	$63.47 - $69.35 $24,055 - $26,283	-379 Reduced 74.46%	130 $9,000
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $180 - $205	3 Added 0.59%	509 $33,000
Q4 2020 Jan 27, 2021	BUY	$56.65 - $64.55 $28,664 - $32,662	506 New	506 $30,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Accel Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Accel Wealth Management with notifications on news.